Luptakova Katarina 4
4 · Xilio Therapeutics, Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Luptakova Katarina
CHIEF MEDICAL OFFICER
Transactions
- Award
Restricted Stock Units
2024-01-01+66,500→ 66,500 total→ Common Stock (66,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
- [F2]These RSUs were granted on January 1, 2024 and will vest in four equal annual installments beginning on January 1, 2025 and continuing through January 1, 2028.